NLRP3 and familial dilated cardiomyopathy: In a DCM mouse model induced by streptozotocin (STZ), inhibiting NLRP3 inflammasome activation remarkably improves cardiac function and decreases myocardial hypertrophy induced by hyperglycemia [28].